CAV1 and acne: Recently, it was reported that application of the state‐of‐the‐art treatment with 30% supramolecular salicylic acid in moderate‐to‐severe acne vulgaris indeed provided significantly increased expression of CAV1 in perilesional skin areas, and this expression negatively correlated with the release of inflammatory markers in the affected tissue [14].